Cardinal Health, Inc. (CAH)
- Previous Close
106.00 - Open
106.37 - Bid --
- Ask --
- Day's Range
106.28 - 107.01 - 52 Week Range
77.56 - 116.04 - Volume
105,547 - Avg. Volume
2,296,967 - Market Cap (intraday)
25.959B - Beta (5Y Monthly) 0.70
- PE Ratio (TTM)
42.35 - EPS (TTM)
2.52 - Earnings Date May 2, 2024
- Forward Dividend & Yield 2.00 (1.89%)
- Ex-Dividend Date Mar 28, 2024
- 1y Target Est
115.93
Cardinal Health, Inc. operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. The company operates in two segments, Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products. The segment also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; operates nuclear pharmacies and radiopharmaceutical manufacturing facilities; repackages generic pharmaceuticals and over-the-counter healthcare products; and provides pharmacy management services to hospitals. The Medical segment manufactures, sources, and distributes Cardinal Health branded medical, surgical, and laboratory products and devices that include exam and surgical gloves; needles, syringe, and sharps disposals; compressions; incontinences; nutritional delivery products; wound care products; single-use surgical drapes, gowns, and apparels; fluid suction and collection systems; urology products; operating room supply products; and electrode product lines. The segment also distributes a range of national brand products, including medical, surgical, and laboratory products; provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare providers; and assembles and sells sterile, and non-sterile procedure kits. The company was incorporated in 1979 and is headquartered in Dublin, Ohio.
www.cardinalhealth.comRecent News: CAH
Performance Overview: CAH
Trailing total returns as of 4/19/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: CAH
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: CAH
Valuation Measures
Market Cap
25.78B
Enterprise Value
25.91B
Trailing P/E
42.06
Forward P/E
13.61
PEG Ratio (5yr expected)
0.31
Price/Sales (ttm)
0.12
Price/Book (mrq)
--
Enterprise Value/Revenue
0.12
Enterprise Value/EBITDA
13.70
Financial Highlights
Profitability and Income Statement
Profit Margin
0.30%
Return on Assets (ttm)
2.79%
Return on Equity (ttm)
--
Revenue (ttm)
216.15B
Net Income Avi to Common (ttm)
639M
Diluted EPS (ttm)
2.52
Balance Sheet and Cash Flow
Total Cash (mrq)
4.59B
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
3.84B
Research Analysis: CAH
Analyst Price Targets
Fair Value
Analyst Recommendations
- Strong Buy
- Buy
- Hold
- Underperform
- Sell
Earnings
Research Reports: CAH
Weekly Stock List
Management's ability to "raise guidance" can often be a catalyst for market-beating returns in the quarters ahead. The fourth-quarter earnings season has crossed the 95% mark and is wrapping up, with blended earnings (actual results and the consensus for those still to report) showing a year-over-year gain of almost 10%, according to Refinitiv. That is considerably better than the 4%-7% advance expected at the start of the earnings period. Leading the outperformance were strong gains in Communication Services earnings, up 53%. On the flipside, Energy (like last quarter) is performing the worst, down 22%. Our analysts are always on the lookout for companies that boost their outlooks during earnings season. Here is an initial list of BUY-rated companies in Argus' Fundamental Universe of Coverage at which management raised guidance or increased its outlook during the 4Q23 EPS reporting season.
Analyst Report: Cardinal Health, Inc.
Cardinal is one of the nation's largest pharmaceutical and medical distribution companies. Its Pharmaceutical segment distributes a wide range of branded and generic drugs, specialty drugs, and over-the-counter products. The Medical segment distributes medical, surgical, and laboratory products to hospitals and other healthcare providers. The company has about 44,000 employees. The shares are a component of the S&P 500.
RatingBullishPrice TargetMarket Digest: ASH, CAH, CL, FCX, HOG, SPG, TROW, HLT, PYPL
U.S. equities inched higher on Thursday despite regional bank woes and ahead of the CPI revisions that will be released this morning. After hitting 5000 for the first time ever, the S&P 500 closed just below 5000. The Dow also closed at an all-time high. Big stock gainers include Arm Holdings PLC (ARM), up 48% and Ralph Lauren Corp. (RL), up 25%. The S&P 500 closed up less than 0.1%, the Dow was up 0.1% and the Nasdaq gained 0.2%. Crude oil rose above $76 per barrel and gold was up $1 to $2049 per ounce.
Analyst Report: Cardinal Health, Inc.
Cardinal Health is one of three leading pharmaceutical wholesalers in the U.S., engaged in sourcing and distributing of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with Cencora and McKesson, the three comprise well over 90% of the U.S. pharmaceutical wholesale industry. Cardinal Health also supplies medical-surgical products and equipment to healthcare facilities in North America, Europe, and Asia.
RatingBearishPrice Target